ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2021

Lipoxygenase inhibitor ML351 dysregulated an innate inflammatory response leading to impaired cardiac repair in acute heart failure.

Bochra Tourki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.